Stocks · Health care · Biological Products, (No Diagnostic Substances)

Artiva Biotherapeutics, Inc.

ARTV Clue Score30
United States Fiscal year ends December CIK 0001817241 Results filed 27 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Fred Aslan
2 Nov 2026
Chief Executive Officer
Sell
62,178
$4.18
$259.97K
Subhashis Banerjee
2 Nov 2026
Chief Medical Officer
Sell
1,110
$4.18
$4.64K
Jennifer Bush
2 Nov 2026
COO, CLO, Compliance Officer
Sell
8,439
$4.18
$35.28K
Christopher Horan
2 Nov 2026
Chief Tech Operations Officer
Sell
10,423
$4.18
$43.58K
Fred Aslan
5 Oct 2026
Chief Executive Officer
Sell
61,696
$6.84
$421.83K
Subhashis Banerjee
5 Oct 2026
Chief Medical Officer
Sell
1,099
$6.84
$7.51K
Jennifer Bush
5 Oct 2026
COO, CLO, Compliance Officer
Sell
8,370
$6.84
$57.23K
Christopher Horan
5 Oct 2026
Chief Tech Operations Officer
Sell
10,340
$6.84
$70.70K
Fred Aslan
3 Sep 2026
Chief Executive Officer
Sell
61,888
$11.16
$690.39K
Subhashis Banerjee
3 Sep 2026
Chief Medical Officer
Sell
1,100
$11.16
$12.27K
Jennifer Bush
3 Sep 2026
COO, CLO, Compliance Officer
Sell
8,391
$11.16
$93.61K
Christopher Horan
3 Sep 2026
Chief Tech Operations Officer
Sell
10,366
$11.16
$115.64K
Fred Aslan
19 May 2026
Chief Executive Officer
Sell
27,116
$9.01
$244.25K
Subhashis Banerjee
19 May 2026
Chief Medical Officer
Sell
7,037
$9.01
$63.39K
Jennifer Bush
19 May 2026
COO, CLO, Compliance Officer
Sell
8,790
$9.01
$79.18K
Christopher Horan
19 May 2026
Chief Tech Operations Officer
Sell
7,002
$9.01
$63.07K
Heather Raymon
19 May 2026
SVP, Research and Development
Sell
3,095
$9.01
$27.88K

What was left out

Form 4 filings counted 103
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 17
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 2
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 12,059,136
History held since 22 Jul 2024